Back
Rigel Pharmaceuticals 10K Form
Buy
54
RIGL
Rigel Pharmaceuticals
Last Price:
$18.79
Seasonality Move:
5.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2023-11-07 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2023-08-01 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2023-05-02 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2022-11-03 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2022-08-02 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
Receive RIGL News And Ratings
See the #1 stock for the next 7 days that we like better than RIGL
RIGL Financial Statistics
Sales & Book Value
| Annual Sales: | $179.3M |
|---|---|
| Cash Flow: | $-893K |
| Price / Cash Flow: | 9.48 |
| Annual Sales: | $1.04 |
| Price / Book: | 18.22 |
Profitability
| EPS (TTM): | 2.07000 |
|---|---|
| Net Income (TTM): | $37.2M |
| Gross Margin: | $160.6M |
| Return on Equity: | 0% |
| Return on Assets: | 25.32% |
Rigel Pharmaceuticals Earnings Forecast
Key Rigel Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 26 years for RIGL is 89.60%.
-
The Selling, General & Administrative Expenses for RIGL have been equal to 63.06% of Gross Profit Margin.
-
The Research & Development expenses have been 13.04% of Revenue.
-
The Interest Expense is 45.28% of Operating Income.
-
The Net Earning history of RIGL is 9.75% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 18 years.
Rigel Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RIGL |
| CUSIP: | 766559 |
| Website: | rigel.com |
Debt
| Debt-to-Equity Ratio: | 3.22 |
|---|---|
| Current Ratio: | 2.2 |
| Quick Ratio: | 1.78 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.12 |
|---|---|
| Forward P/E Ratio: | 9.54 |
RIGL Technical Analysis vs Fundamental Analysis
Buy
54
Rigel Pharmaceuticals (RIGL)
is a Buy
Is Rigel Pharmaceuticals a Buy or a Sell?
-
Rigel Pharmaceuticals stock is rated a BuyThe current Rigel Pharmaceuticals [RIGL] share price is $18.93. The Score for RIGL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.